ReviewPublished 14 September 2026Animal reuse in safety assessment studies: a review of current practices, challenges and 3Rs opportunitiesJohn S. Kendrick · David A. Shaw · Marie Jourdain · Claudia Senn · Helen Beyer · Fiona R. SewellFrontiers in Toxicologydoi 10.3389/ftox.2026.1854281
ReviewPublished 30 April 2026From biosimilars to breakthroughs: regulatory convergence toward evidence-efficient development of monoclonal antibodiesSarfaraz K. NiaziFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1778468
ReviewPublished 15 April 2026Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworksSarfaraz K. NiaziFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1801236
